Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 10, 2018 19:33 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Achieves Industry’s First Hemp Extract GRAS Self-Affirmation

First Hemp Extract to Achieve Highly Sought-After Self-Affirmed GRAS Status Designation LAS VEGAS, Sept. 10, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”,...
September 05, 2018 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. to Present and Exhibit as Gold Sponsor at Natural Products Expo East 2018 in Baltimore, Maryland, September 12-15, 2018

Company enters its 3rd year sponsoring and exhibiting at the nation's second largest natural products trade show, offering natural health retailers show specials, one-on-one education, and a wide...
August 30, 2018 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. provides corporate update to shareholders

LAS VEGAS, Aug. 30, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) would like to assure our shareholders that we are keenly aware of recent...
August 28, 2018 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Responds to Class Action Lawsuit

LAS VEGAS, Aug. 28, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) has been informed of a class action lawsuit filed against the Company...
August 22, 2018 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Repays Remaining Debt

LAS VEGAS, Aug. 22, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced today that it has fully repaid the promissory note payable...
August 08, 2018 08:45 ET | Source: CV Sciences, Inc.

World-Renowned Neurosurgeon, Health and Nutrition Expert, Dr. Joseph Maroon, Joins CV Sciences, Inc. Board of Directors

LAS VEGAS, Aug. 08, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company,” “CV Sciences,” “our” or “we”) is pleased to announce the appointment of Joseph Maroon, MD, FACS (“Dr....
August 01, 2018 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Reports Second Quarter 2018 Financial Results

Growth and Profitability Driven by Key Financial Performance Metrics, including Record GAAP Net Income of $3.2 MillionManagement to Host Second Quarter 2018 Financial Results Conference Call on August...
July 25, 2018 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Pre-Announces Record Second Quarter 2018 Sales

Company Expects to Report Sales of $12.3 Million, up 203% from the same quarter in 2017 Will Host Earnings Call on Wednesday, August 1, 2018 LAS VEGAS, July 25, 2018 (GLOBE NEWSWIRE) -- CV...
July 23, 2018 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Files Application for Up-Listing to the NASDAQ Capital Market

LAS VEGAS, July 23, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including cannabidiol (CBD) oil and developer of...
July 20, 2018 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. to Host Second Quarter 2018 Financial Results Conference Call on Wednesday August 1, 2018

LAS VEGAS, July 20, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including cannabidiol (CBD) oil and developer of...